Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials

Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials

Abstract Background The role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) reducing risk of cardiovascular events (CVEs) and preserving kidney function in patients with chronic kidney disease is well-documented. However, the efficacy and safety of these...

Full description

Bibliographic Details
Main Authors: Youxia Liu, Xinxin Ma, Jie Zheng, Junya Jia, Tiekun Yan
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Nephrology
Subjects:
Angiotensin-converting enzyme inhibitors
Angiotensin receptor blockers
Cardiovascular events
Residual renal function
Dialysis
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12882-017-0605-7

Internet

http://link.springer.com/article/10.1186/s12882-017-0605-7

Similar Items